Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Canadian Sec - Delayed Quote CAD

NanoSphere Health Sciences Inc. (NSHS.CN)

0.0550
0.0000
(0.00%)
At close: April 29 at 3:56:30 PM EDT
Loading Chart for NSHS.CN
  • Previous Close 0.0550
  • Open 0.0000
  • Bid --
  • Ask --
  • Day's Range 0.0000 - 0.0000
  • 52 Week Range 0.0000 - 0.1750
  • Volume 0
  • Avg. Volume 5,245
  • Market Cap (intraday) 565,136
  • Beta (5Y Monthly) 0.90
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0100
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

NanoSphere Health Sciences Inc., a nano-biotechnology company, focuses on providing biologically active compounds in the United States and Canada. It offers NanoSphere Delivery System, a platform using nanotechnology in the bio delivery of supplements, nutraceuticals, and over-the-counter medications for the cannabis, pharmaceutical, and animal health industries. NanoSphere Health Sciences Inc. is headquartered in Vancouver, Canada.

www.jphres.org/nanospherehealth

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: NSHS.CN

View More

Performance Overview: NSHS.CN

Trailing total returns as of 5/7/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

NSHS.CN
22.22%
S&P/TSX Composite index (^GSPTSE)
2.20%

1-Year Return

NSHS.CN
120.00%
S&P/TSX Composite index (^GSPTSE)
12.88%

3-Year Return

NSHS.CN
35.29%
S&P/TSX Composite index (^GSPTSE)
21.94%

5-Year Return

NSHS.CN
89.00%
S&P/TSX Composite index (^GSPTSE)
69.62%

Compare To: NSHS.CN

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: NSHS.CN

View More

Valuation Measures

Annual
As of 5/7/2025
  • Market Cap

    565.14k

  • Enterprise Value

    592.88k

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -541.10%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -199.03k

  • Diluted EPS (ttm)

    -0.0100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    11.81k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    56.28k

Research Analysis: NSHS.CN

View More

Company Insights: NSHS.CN

Research Reports: NSHS.CN

View More

People Also Watch